Intellectual Property India Publishes Patent Application for Pyrazolyl Compounds As Emopamil Binding Protein Inhibitors

MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202617035646 A) filed by Genzyme Corporation on March 24, 2026, for Pyrazolyl Compounds As Emopamil Binding Protein Inhibitors.

Inventors include Jiang, John Ziqi; Lim, Sungtaek; Merriman, Gregory H.; Mueller, Paul Justin; and Thurairatnam, Sukanthini.

The application for the patent was published on August 07, 2026, under issue no. 32/2026.

Abstract: Provided herein are compounds and pharmaceutical compositions thereof for inhibiting Emopamil Binding Protein (EBP) and their use in the treatment of demyelinating diseases such as multiple sclerosis.

Disclaimer: Curated by HT Syndication.